Nate Silver looks at the Hall of Fame voting

38 Comments

Nate Silver — with a strong assist from @leokitty, who has compiled a spreadsheet of public Hall of Fame votes — gives those public Hall of Fame votes the old Nate Silver treatment in his latest post.

Specifically, he looks for patterns among voters who did and didn’t vote for Barry Bonds and/or Roger Clemens in an attempt to see what that means for others on the ballot. The upshot: while Bonds and Clemens represent a clear and unambiguous case of voters weighing in on the steroid era for good or for ill, the suction is taking guys like Bagwell and Piazza down with them.  Which, if you’re not yet sick of my Hall of Fame posts here, you’re well aware of.

Silver notes, however, that that suction, well, sucks, because it’s based on some pretty crude and inaccurate stereotyping by the electorate. Because — based on the sorts of players who have been suspended for performance-enhancing drugs, it makes little sense to simply assume use by the big guys and assume that the little guys were clean:

Among these players are the utility infielder Neifi Perez, who hit 64 home runs in a 12-year career, the slap-hitting outfielder Jorge Piedra, and a substantial number of pitchers. The incidence of performance-enhancing drug use seems to be fairly randomly distributed between stars and benchwarmers, players at different positions and those with different skills.

Some writers seem to think they can profile steroid users, and some otherwise-deserving players seem likely to be denied a place in Cooperstown because of it.

Report: Yankees to promote Gleyber Torres

Yankees Torres Baseball
AP Images
2 Comments

Yankees top prospect Gleyber Torres will be promoted to the majors this weekend, per a report from Jack Curry of the YES Network. Torres was expected to make his debut earlier in the season, but his starting date was pushed back after he suffered a bout of back tightness last Monday. Now, however, it looks like he’s finally healthy enough to make an impact on a team that’s in sore need of an offensive boost. As of Saturday evening, the team has yet to officially confirm the move.

The 21-year-old infielder has made quite the impression in Triple-A Scranton/Wilkes-Barre this spring, slashing .370/.415/.543 with five extra-base hits and 11 RBI in his first 53 plate appearances. Prior to the start of the 2018 season, he was ranked first overall in the Yankees’ system and fifth among the league’s best prospects (via MLB Pipeline). His numbers at the plate have been made all the more impressive by the fact that he’s only 10 months removed from Tommy John surgery on his non-throwing arm; neither the injury nor the lengthy recovery process seems to have had any detrimental effect on his game play this year.

While Torres appears most comfortable as a shortstop, he’s not expected to supplant Didi Gregorius in a starting role. Instead, it’s more likely that he’ll sub in at second and third base among the likes of Miguel Andujar, Neil Walker and Ronald Torreyes.